577 related articles for article (PubMed ID: 17112795)
21. Impact of sample preparation in peptide/protein profiling in human serum by MALDI-TOF mass spectrometry.
Aresta A; Calvano CD; Palmisano F; Zambonin CG; Monaco A; Tommasi S; Pilato B; Paradiso A
J Pharm Biomed Anal; 2008 Jan; 46(1):157-64. PubMed ID: 18035512
[TBL] [Abstract][Full Text] [Related]
22. Serum peptidome patterns of human systemic lupus erythematosus based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
Dai Y; Hu C; Wang L; Huang Y; Zhang L; Xiao X; Tan Y
Scand J Rheumatol; 2010 May; 39(3):240-6. PubMed ID: 20166849
[TBL] [Abstract][Full Text] [Related]
23. Biomarker discovery from body fluids using mass spectrometry.
Villar-Garea A; Griese M; Imhof A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359
[TBL] [Abstract][Full Text] [Related]
24. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
25. In-source decay causes artifacts in SELDI-TOF MS spectra.
Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
[TBL] [Abstract][Full Text] [Related]
26. FTMS and TOF/TOF mass spectrometry in concert: identifying peptides with high reliability using matrix prespotted MALDI target plates.
Dekker LJ; Burgers PC; Guzel C; Luider TM
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):62-4. PubMed ID: 16963321
[TBL] [Abstract][Full Text] [Related]
27. A new rapid and comprehensive peptidome analysis by one-step direct transfer technology for 1-D electrophoresis/MALDI mass spectrometry.
Tanaka K; Tsugawa N; Kim YO; Sanuki N; Takeda U; Lee LJ
Biochem Biophys Res Commun; 2009 Jan; 379(1):110-4. PubMed ID: 19073144
[TBL] [Abstract][Full Text] [Related]
28. Chip-LC-MS for label-free profiling of human serum.
Horvatovich P; Govorukhina NI; Reijmers TH; van der Zee AG; Suits F; Bischoff R
Electrophoresis; 2007 Dec; 28(23):4493-505. PubMed ID: 18041038
[TBL] [Abstract][Full Text] [Related]
29. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples.
Rai AJ; Gelfand CA; Haywood BC; Warunek DJ; Yi J; Schuchard MD; Mehigh RJ; Cockrill SL; Scott GB; Tammen H; Schulz-Knappe P; Speicher DW; Vitzthum F; Haab BB; Siest G; Chan DW
Proteomics; 2005 Aug; 5(13):3262-77. PubMed ID: 16052621
[TBL] [Abstract][Full Text] [Related]
30. Effects of pretreatment protocols on human amniotic fluid protein profiling with SELDI-TOF MS using protein chips and magnetic beads.
Deng B; Dong Z; Liu Y; Wang C; Liu J; Wang C; Qu X
Clin Chim Acta; 2010 Aug; 411(15-16):1051-7. PubMed ID: 20361951
[TBL] [Abstract][Full Text] [Related]
31. Proteomic profiling of ovine serum by SELDI-TOF MS: optimisation, reproducibility and feasibility of biomarker discovery using routinely collected samples.
Zhong L; Taylor DL; Whittington RJ
Comp Immunol Microbiol Infect Dis; 2010 Jan; 33(1):47-63. PubMed ID: 18775566
[TBL] [Abstract][Full Text] [Related]
32. Serum protein profiling by miniaturized solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
Callesen AK; Mohammed S; Bunkenborg J; Kruse TA; Cold S; Mogensen O; Christensen Rd; Vach W; Jørgensen PE; Jensen ON
Rapid Commun Mass Spectrom; 2005; 19(12):1578-86. PubMed ID: 15915448
[TBL] [Abstract][Full Text] [Related]
33. Short monolithic columns for purification and fractionation of peptide samples for matrix-assisted laser desorption/ionization time-of-flight/time-of-flight mass spectrometry analysis in proteomics.
Moravcová D; Kahle V; Rehulková H; Chmelík J; Rehulka P
J Chromatogr A; 2009 Apr; 1216(17):3629-36. PubMed ID: 19217112
[TBL] [Abstract][Full Text] [Related]
34. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
[TBL] [Abstract][Full Text] [Related]
35. ProteoMiner™ and SELDI-TOF-MS: a robust and highly reproducible combination for biomarker discovery from whole blood serum.
Fröbel J; Hartwig S; Passlack W; Eckel J; Haas R; Czibere A; Lehr S
Arch Physiol Biochem; 2010; 116(4-5):174-80. PubMed ID: 20662595
[TBL] [Abstract][Full Text] [Related]
36. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
37. A new analytical material-enhanced laser desorption ionization (MELDI) based approach for the determination of low-mass serum constituents using fullerene derivatives for selective enrichment.
Vallant RM; Szabo Z; Trojer L; Najam-ul-Haq M; Rainer M; Huck CW; Bakry R; Bonn GK
J Proteome Res; 2007 Jan; 6(1):44-53. PubMed ID: 17203947
[TBL] [Abstract][Full Text] [Related]
38. Matrix layer sample preparation: an improved MALDI-MS peptide analysis method for proteomic studies.
Garaguso I; Borlak J
Proteomics; 2008 Jul; 8(13):2583-95. PubMed ID: 18546159
[TBL] [Abstract][Full Text] [Related]
39. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
40. Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry.
de Noo ME; Tollenaar RA; Ozalp A; Kuppen PJ; Bladergroen MR; Eilers PH; Deelder AM
Anal Chem; 2005 Nov; 77(22):7232-41. PubMed ID: 16285670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
